News at a glance.
Galenica again achieves strong sales growth
Ad hoc announcement pursuant to Art. 53 LR, Thursday, 18 January 2024
Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.3% in the second half of 2023 was lower than the +5.5% recorded in the first half due to the exceptionally strong comparative period in the second half of 2022, when there was a strong seasonal flu epidemic and COVID-19 infections.
News at a glance
Here you will find all ad hoc announcements, press releases and news about the Galenica network. Stay up to date and subscribe to our ad hoc announcements and press releases by e-mail.
Latest ad hoc announcements and press releases
All relevant news from the Galenica network in our ad hoc announcements and press releases.
Downloads for media
Images of various business activities from the Galenica network and the Galenica logo for journalistic use.
«We demonstrate how we create added value within the Galenica network; for our customers, employees, investors, partners and Switzerland’s healthcare system.»
Iris Müller, Head of Corporate Communications